[
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Neurotensin-receptor-NTS-1-aptamer.html",
    "New Linker name":"Neurotensin receptor NTS-1 aptamer",
    "Aptamer Name":"P19 aptamer",
    "Target":"PDAC",
    "Conjugated drug":"Monomethyl auristatin E,maytansine 1",
    "Disease":"Breast cancer",
    "Clinical Status":"Preclinical research",
    "Sequence":"5'-AGGACGATGCGGACAGATACGGAACTACAGAGGTCAATTACGGTGGCCACGCCAGACGACTCGCCCGA-3'",
    "Length":68,
    "GC content":0.588,
    "Affinity":"Kd: 0.37 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/28325302\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Neurotensin-receptor-NTS-1-aptamer.html",
    "New Linker name":"Neurotensin receptor NTS-1 aptamer",
    "Aptamer Name":"P19 aptamer",
    "Target":"PDAC",
    "Conjugated drug":"5-fluorouracil,Gemcitabine",
    "Disease":"Pancreatic cancer",
    "Clinical Status":"Preclinical research",
    "Sequence":"5'-AGGACGATGCGGACAGATACGGAACTACAGAGGTCAATTACGGTGGCCACGCCAGACGACTCGCCCGA-3'",
    "Length":68,
    "GC content":0.588,
    "Affinity":"Kd: 0.37 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/28325302\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/PSMA-aptamer.html",
    "New Linker name":"PSMA aptamer",
    "Aptamer Name":"A9g aptamer",
    "Target":"PSMA",
    "Conjugated drug":"Doxorubicin",
    "Disease":"Prostate cancer",
    "Clinical Status":"Preclinical research",
    "Sequence":"5'-GGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCC-3'",
    "Length":43,
    "GC content":0.47,
    "Affinity":"Kd: 5-30 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/21147500\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/PSMA-aptamer.html",
    "New Linker name":"PSMA aptamer",
    "Aptamer Name":"A9g aptamer",
    "Target":"PSMA",
    "Conjugated drug":"Epirubicin",
    "Disease":"Prostate cancer",
    "Clinical Status":"Preclinical research",
    "Sequence":"5'-GGGACCGAAAAAGACCUGACUUCUAUACUAAGUCUACGUUCCC-3'",
    "Length":43,
    "GC content":0.47,
    "Affinity":"Kd: 5-30 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/23815443\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/HER2-aptamer",
    "New Linker name":"HER2 aptamer",
    "Aptamer Name":"Her2 aptamer",
    "Target":"HER2",
    "Conjugated drug":"mertansine 1",
    "Disease":"Breast cancer",
    "Clinical Status":"Preclinical research",
    "Sequence":"TSA14 aptamer: 5'-GCUGGAGCAUUUAUGGAUGAACCUUGGACGGAA-3'\nTSA12 aptamer: 5'-GAAAGUGAGAGUCGAUUUAGCAACAGAGAGUGAGG-3'",
    "Length":"33\n35",
    "GC content":"48%\n46%",
    "Affinity":"Kd:  133.9±12.78 nM\nKd: 191.9±21.77 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/33371333\/"
  }
]